Showing results (2661-2670 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|August 22, 2014
CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinomaBritnie R James, Kristin G Anderson, Erik L Brincks, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2013
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patientsWillemijn Hobo, Leonie Strobbe, Frans Maas, et al.
Cancer Immunology, Immunotherapy : CII|June 19, 2013
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashionSara Fritzell, Emma Sandén, Sofia Eberstål, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Effect of recombinant human tumor necrosis factor alpha on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodulesA Eisenthal, J K McIntosh
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Common variable immunodeficiency and malignancy: a report of two cases and possible explanation for the associationI Vorechovsky, J Litzman, J Lokaj, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Tumour targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastasesS Matzku, H Krempel, H P Weckenmann, et al.
Cancer Immunology, Immunotherapy : CII|June 14, 2013
Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patientsAng Huang, Bo Zhang, Bo Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2013
Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trialRyan D Guest, Natalia Kirillova, Sam Mowbray, et al.
Cancer Immunology, Immunotherapy : CII|September 10, 2013
Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomasVeronica Langenes, Helena Svensson, Lars Börjesson, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2013
Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotypeJoachim Rudolf Göthert, Lewin Eisele, Ludger Klein-Hitpass, et al.
Pageof 652